CSL Behring wins major
June 10, 2016
CSL Behring’s Australian facility
was last night awarded ‘2016
Victorian Manufacturer of the Year’
in the Large Business category at
the Victorian Manufacturing Hall of
Fame Awards.
CSL Behring operates one of the
world’s largest plasma collection
networks CSL Plasma, with global
biotherapeutics Australian-listed
company CSL Limited as parent.
As the nation’s national plasma
fractionator since 1953 CSL Behring
has played an important role in
ensuring the supply of life-saving
plasma products for Australians.
Recently, the Broadmeadows
facility has augmented its longstanding
Australian product
portfolio with a major new facility
that enables the processing of
US-collected plasma intermediate
to manufacture of the company’s
immune system disorder product
Privigen.
The new facility absorbed an
investment of five years through
its design and construction phase,
with the first batch of Privigen
exported in Dec 2015 to treat
patients in the United States, the
company said.
Technical and scientific aspects
were the result of international
collaboration within CSL’s global
network.
CSL Behring Australia gm Martin
Schaeren said, “We are delighted
to be Victorian Manufacturer of the
Year and to showcase the potential
of advanced manufacturing in
Australia.
“It is particularly serendipitous for
us to receive this award in 2016 as
this year we are celebrating CSL’s
centenary and the generations of
scientists, medical professionals
and governments whose passion
and commitment have played a
role in making CSL the globally
successful, innovative company it
is today.”
More than 900 employees work
at CSL Behring’s Broadmeadows
manufacturing facility and around
250 of these staff support the
new Privigen and Biotechnology
Manufacturing facilities.
The above article was sent to subscribers in Pharmacy Daily's issue from 10 Jun 16To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Jun 16
